يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Leïla Belkhir"', وقت الاستعلام: 0.65s تنقيح النتائج
  1. 1

    المساهمون: UCL - SSS/LDRI - Louvain Drug Research Institute, UCL - SSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology, UCL - SSS/IREC/FATH - Pôle de Pharmacologie et thérapeutique, UCL - SSS/DDUV - Institut de Duve, UCL - SSS/DDUV/BCHM - Biochimie-Recherche métabolique, UCL - SSS/DDUV/CBIO - Computational Biology and Bioinformatics, UCL - SSS/DDUV/PHOS - Protein phosphorylation, UCL - (SLuc) Service de médecine interne générale, UCL - (SLuc) Service de biochimie médicale, UCL - (SLuc) Service de microbiologie

    المصدر: Viruses, Vol. 14, no. 7, p. 1373 [1-17] (2022)

  2. 2

    المساهمون: UCL - SSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de microbiologie, UCL - (SLuc) Service de médecine interne générale, UCL - (SLuc) Service de neurochirurgie

    المصدر: Surgical infections, Vol. 23, no.4, p. 388-393 (2022)

  3. 3

    المساهمون: Belgian Collaborative Grp COVID-19, Sociology, UCL - SSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology, UCL - (SLuc) Service de médecine interne générale

    المصدر: International Journal of Antimicrobial Agents
    International journal of antimicrobial agents
    International journal of antimicrobial agents, 56 (4
    International journal of antimicrobial agents, Vol. 56, no.4, p. 106144 [1-8] (2020)

    مصطلحات موضوعية: Male, 0301 basic medicine, Antimalarials -- therapeutic use, Epidemiology, T-Lymphocytes, AZITHROMYCIN, Pneumonia, Viral -- diagnostic imaging -- drug therapy -- mortality -- pathology, CORONAVIRUS, Azithromycin, 0302 clinical medicine, Observational study, Hydroxychloroquine -- therapeutic use, Betacoronavirus -- drug effects -- pathogenicity, Drug Dosage Calculations, Pharmacology (medical), Pharmacology & Pharmacy, hospitalised patients, Hospital Mortality, 030212 general & internal medicine, Medicine(all), Aged, 80 and over, Pharmacology. Therapy, Hazard ratio, General Medicine, Sciences bio-médicales et agricoles, Middle Aged, Prognosis, Letter to The Editor, Intensive Care Units, C-Reactive Protein, Treatment Outcome, Infectious Diseases, Disease Progression, Female, Patient Safety, Coronavirus Infections, Life Sciences & Biomedicine, Hydroxychloroquine, medicine.drug, Adult, Microbiology (medical), medicine.medical_specialty, Adolescent, Coronavirus disease 2019 (COVID-19), Pneumonia, Viral, 030106 microbiology, Coronavirus Infections -- diagnostic imaging -- drug therapy -- mortality -- pathology, Microbiology, Article, Antimalarials, Betacoronavirus, 03 medical and health sciences, Immunology and Microbiology(all), Internal medicine, medicine, Humans, Mortality, Biology, Pandemics, Aged, Proportional Hazards Models, Retrospective Studies, Science & Technology, SARS-CoV-2, Proportional hazards model, business.industry, Drug Repositioning, COVID-19, C-Reactive Protein -- metabolism, Retrospective cohort study, T-Lymphocytes -- pathology -- virology, Confidence interval, Low-dose hydroxychloroquine therapy, observational study, Human medicine, Tomography, X-Ray Computed, business

    وصف الملف: 2 full-text file(s): application/pdf; application/pdf; Print-Electronic